Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: Insights from the Platelet Inhibition and Patient Outcomes trial-Reference-Cited by-同舟云学术

Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: Insights from the Platelet Inhibition and Patient Outcomes trial

Published:2015-06 Issue:6 Volume:169 Page:879-889.e7
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Velders Matthijs A.,Wallentin Lars,Becker Richard C.,van Boven Adrianus J.,Himmelmann Anders,Husted Steen,Katus Hugo A.,Lindholm Daniel,Morais Joao,Siegbahn Agneta,Storey Robert F.,Wernroth Lisa,James Stefan K.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;O'Gara;J Am Coll Cardiol,2013

2. Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction;Jernberg;JAMA,2011

3. Sex- and age-related differences in clinical outcome after primary percutaneous coronary intervention;Jakobsen;EuroIntervention,2012

4. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE);Fox;BMJ,2006

5. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy;Morrow;Circulation,2000

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence and mechanism of sodium-glucose cotransporter-2 inhibitors on the cardiac function: study protocol for a prospective cohort study;Frontiers in Endocrinology;2023-07-19

2. The Novel Biomarker Growth Differentiation Factor-15 in Patients with Chronic Heart Failure at a Heart Failure Clinic in the Asia-Pacific Region: A Prospective Observational Study;Journal of Asian Pacific Society of Cardiology;2023-05-26

3. Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial;Circulation: Heart Failure;2023-05

4. Prognostic value of growth differentiation factor-15 in patients with coronary artery disease: A meta-analysis and systematic review;Frontiers in Cardiovascular Medicine;2023-02-10

5. Inflammageing and Cardiovascular System: Focus on Cardiokines and Cardiac-Specific Biomarkers;International Journal of Molecular Sciences;2023-01-03